Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genus PLC Director's Dealing 2017

Mar 15, 2017

4873_rns_2017-03-15_56320ebe-92a3-440e-9bad-0515b43fb91d.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6074Z

Genus PLC

15 March 2017

15 March 2017

Genus plc

Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 15 March 2017 under the Genus 2004 Performance Share Plan (the 'PSP') as listed in the table below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus today on the London Stock Exchange partly to offset income tax and social security liabilities due on the exercise.  A total of 2,951 ordinary shares have been retained by the GELT member. 

The below notification gives further details of the number of share options exercised and ordinary shares sold today.

For further information please contact:

Genus:

Cara Crichton, Deputy Company Secretary                                                                           Tel: +44 (0)1256 347100

1.           

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Dr Jonathan Lightner

2.            

Reason for the notification

a.            

Position/status

Chief R&D and Scientific Officer

b.            

Initial notification

/Amendment

Initial notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.           

LEI

54930022EOITNKSIGH56

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.            

Nature of the transaction

Exercise of 9,683 nil-cost options under the PSP.

c.            

Price(s) and volume(s)

Price(s) Volume(s)
0p 9,683

d.            

Aggregated information

·     Aggregated volume

·     Price

n/a

e.            

Date of the transaction

2017-03-15

f.            

Place of the transaction

London Stock Exchange, Main Market (XLON)

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.

Nature of the transaction

Sale of 6,732 shares arising from the exercise of nil-cost options under the PSP partly to offset income tax and social security liabilities due on the exercise.  The balance of 2,951 shares following the exercise has been retained by Dr Jonathan Lightner.

c.

Price(s) and volume(s)

Price(s) Volume(s)
1,813.94p 6,732

d.

Aggregated information

·     Aggregated volume

·     Price

n/a

e.

Date of the transaction

2017-03-15

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUVABRBUAOAAR